Czechia· CZ-0272210

VELSIPITY

A etrasimod product containing etrasimod arginine, registered in Czechia by Pfizer Europe MA EEIG, Bruxelles. The same ATC class is registered in 13 of our 19 countries.

ATC L04AE05

Checked against SÚKL (Czech Republic) on

Informational only — not a medical device.

SOURCE REGISTER · CZSÚKL (Czech Republic)normalisedVELSIPITYATCL04AE05REGISTER NO.CZ-0272210PACKS LISTED0CHECKEDSeptember 28, 2026

Where it is registered

Etrasimod is registered in 13 of 19 countries.

Countries holding a registration under ATC L04AE05 (etrasimod), each read from that country’s own register.

  • This record: Czechia, from SÚKL (Czech Republic)
  • 8 of them publish a price we can compare per daily dose

Etrasimod · ATC L04AE05

13 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Icelandprice
  • Ireland
  • Netherlands
  • Norwayprice
  • Polandprice
  • Spainprice
  • Switzerlandprice
  • United Kingdom
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of etrasimod costs, country by country.

Normalised to the WHO defined daily dose (2 mg), so markets compare like for like.

  • 1 market with a comparable price for this class
  • Public list prices, converted to USD at the rate date shown

Etrasimod · price per daily dose (2 mg)

USD · FX 28 Sept 2026

  • CH Switzerland$35.97
Median listed price per WHO defined daily dose, in each market that publishes a price. Open the full comparison

The record

At a glance

SÚKL (Czech Republic)
Active substance
ETRASIMOD ARGININE
Manufacturer
Pfizer Europe MA EEIG, Bruxelles
Country
Czechia (CZ)
ATC code
L04AE05
ATC class
Etrasimod
Defined daily dose
2 mg, O
Reimbursed
Not published by this register
Source register
SÚKL (Czech Republic)
Last checked
September 28, 2026

Packs & prices · 0

No packs listed by the register for this record.

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of SÚKL (Czech Republic). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/92088f66-21ea-4e85-be87-0cf37dd20c70
GET /v1/drugs/92088f66-21ea-4e85-be87-0cf37dd20c70?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "TBL FLM",
  "source": "sukl",
  "strength": "2MG",
  "pack_size": "98",
  "substance": "ETRASIMOD ARGININE",
  "cz_kod_sukl": "0272210",
  "product_type": "CH",
  "substance_codes": "3395",
  "registration_state": "R",
  "registration_number": "EU/1/23/1790/002"
}

See everything about etrasimod.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.